Business

March 19, 2014 10:50 AM

Scynexis eyes $68 million IPO

Durham drug-development company Scynexis hopes to raise up to $68.1 million with an initial public offering of stock.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs